Literature DB >> 23912397

Tracheal stenting has minimal impact on survival in anaplastic thyroid carcinoma.

Parameswaran Rajeev1, Tarek Ezzat, Mark Slade, Gregory Paul Sadler, Radu Mihai.   

Abstract

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is the most aggressive form of thyroid cancer and it has an extremely poor prognosis. Rapid airway compromise is the main cause of death in patients with ATC.
METHODS: The present study is based on a retrospective review of clinical data of patients with ATC treated over the last decade in a tertiary referral center.
RESULTS: Between January 1998 and December 2010, 31 patients (13 males: 18 females) with a mean age of 74 years (range: 54-90 years) had a diagnosis of ATC made on fine-needle aspiration (n = 29) or biopsy (n = 2). Eight patients underwent total thyroidectomy and lymph node dissection, and five patients had attempted surgery but the procedure was abandoned because of inoperability. Airway compromise was clinically apparent in 11 patients. Five patients had tracheal stents inserted, with a median survival of 2 months (range: 1-36 months). In the whole cohort, 29 patients died of the disease, with a mean survival of 7 months (range: 1-36 months).
CONCLUSIONS: Survival of patients with undifferentiated thyroid cancer is severely compromised by airway obstruction. Palliation with tracheal stenting can rescue catastrophic airway obstruction but offers minimal survival benefit.

Entities:  

Mesh:

Year:  2013        PMID: 23912397     DOI: 10.1007/s00268-013-2173-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

1.  Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.

Authors:  E J Junor; J Paul; N S Reed
Journal:  Eur J Surg Oncol       Date:  1992-04       Impact factor: 4.424

2.  Effect of primary treatment on survival in anaplastic thyroid carcinoma.

Authors:  N Besic; M Auersperg; M Us-Krasovec; R Golouh; S Frkovic-Grazio; A Vodnik
Journal:  Eur J Surg Oncol       Date:  2001-04       Impact factor: 4.424

3.  Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis.

Authors:  C Passler; C Scheuba; G Prager; K Kaserer; J A Flores; H Vierhapper; B Niederle
Journal:  Langenbecks Arch Surg       Date:  1999-06       Impact factor: 3.445

4.  Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.

Authors:  Electron Kebebew; Francis S Greenspan; Orlo H Clark; Kenneth A Woeber; Alex McMillan
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

Review 5.  Anaplastic thyroid carcinoma: current diagnosis and treatment.

Authors:  D Giuffrida; H Gharib
Journal:  Ann Oncol       Date:  2000-09       Impact factor: 32.976

6.  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors:  F D Gilliland; W C Hunt; D M Morris; C R Key
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

7.  Increasing incidence of thyroid cancer: controversies explored.

Authors:  Yasuhiro Ito; Yuri E Nikiforov; Martin Schlumberger; Riccardo Vigneri
Journal:  Nat Rev Endocrinol       Date:  2013-01-29       Impact factor: 43.330

8.  Interventional bronchoscopy for treatment of tracheal obstruction secondary to benign or malignant thyroid disease.

Authors:  Marc Noppen; Kris Poppe; Jan D'Haese; Marc Meysman; Brigitte Velkeniers; Walter Vincken
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

9.  Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases.

Authors:  C J Nel; J A van Heerden; J R Goellner; H Gharib; W M McConahey; W F Taylor; C S Grant
Journal:  Mayo Clin Proc       Date:  1985-01       Impact factor: 7.616

10.  Anaplastic thyroid carcinoma: risk factors and outcome.

Authors:  J G Demeter; S A De Jong; A M Lawrence; E Paloyan
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

View more
  4 in total

1.  Bronchoscopic management of critical central airway obstruction by thyroid cancer: Combination airway stenting using tracheal and inverted-Y carinal self-expanding metallic stents.

Authors:  Karan Madan; Prajowl Shrestha; Rakesh Garg; Vijay Hadda; Anant Mohan; Randeep Guleria
Journal:  Lung India       Date:  2017 Mar-Apr

2.  Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients.

Authors:  Adheesh Bhandari; Ying-Hao Wang; Shi-Xu Lv; Er-Jie Xia; Ou-Chen Wang
Journal:  Onco Targets Ther       Date:  2017-10-16       Impact factor: 4.147

3.  Successful management of trachea stenosis with massive substernal goiter via thacheobronchial stent.

Authors:  Meihua Piao; Ye Yuan; Yanshu Wang; Chunsheng Feng
Journal:  J Cardiothorac Surg       Date:  2013-11-15       Impact factor: 1.637

4.  Long Noncoding RNA H19 Inhibits Cell Viability, Migration, and Invasion Via Downregulation of IRS-1 in Thyroid Cancer Cells.

Authors:  Peng Wang; Guoqing Liu; Weimin Xu; Haixia Liu; Qingao Bu; Diwen Sun
Journal:  Technol Cancer Res Treat       Date:  2017-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.